Phase 2a was soft-locked on 4/19/2016 and top-line
Post# of 72436
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
Cellceutix Initiates "Database Soft Lock" On Its Phase 2 Psoriasis Clinical Trial, Top Line Results Expected in May; Additional Company Updates
http://www.ipharminc.com/press-release/2016/1...ny-updates
Cellceutix Phase 2 Trial of Prurisol for Mild to Moderate Psoriasis Meets Primary Endpoint
http://www.ipharminc.com/press-release/2016/1...y-endpoint
I expect to see top-line result in August. I’m being conservative because Phase 2b had almost twice as many patients as Phase 2a. I don’t know whether Friday’s lcok was hard or soft. If it was a hard-lock, result could be released in July.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)